반응식
[Cl:1][C:2]1[C:7](I)=[C:6]([CH2:9][CH3:10])[N:5]=[CH:4][N:3]=1.[CH2:11]([NH2:13])C.C([N:16]([CH2:19][CH3:20])[CH2:17][CH3:18])C.[CH2:21]1[CH2:25]O[CH2:23][CH2:22]1>[Cu]I.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1>[Cl:1][C:2]1[C:7]([C:23]#[C:22][C:21]2[CH:25]=[CH:20][C:19]([NH:16][CH2:17][CH3:18])=[N:13][CH:11]=2)=[C:6]([CH2:9][CH3:10])[N:5]=[CH:4][N:3]=1참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
The title compound is synthesized according to general procedure GP2 starting from 4-chloro-6-ethyl-5-iodo-pyrimidine using 5-Ethynyl-pyridin-2-yl)-ethyl-amine (A-28), CuI, bis-(triphenyl-phoshine)palladium(II) chloride, triethylamine in THF. After work-up the desired compound is obtained in good yield and acceptable purity.
후처리
- customThe title compound is synthesized
출처 및 근거
- ORD 기록
- ord-55f24efa0de6495c89be8542f9f74616
- 출처 데이터셋
- uspto-grants-2014_01
- 특허 번호
- US08633183B2
연결된 노트
불러오는 중…